BioNTech SE (BNTX) Beginning Cash Balance (2018 - 2019)

BioNTech SE (BNTX) Beginning Cash Balance (2018 - 2019) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 BioNTech SE 23.54 Bn 5.15 Bn 668.28 Mn

Historic Data

Download Data
DateValue
Sep 30, 2019 457.88 Mn
Sep 30, 2019 457.88 Mn
Sep 30, 2018 200.18 Mn
Sep 30, 2018 200.18 Mn